Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grant, S. M.
Right arrow Articles by Cantorna, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grant, S. M.
Right arrow Articles by Cantorna, M. T.

© 2003 The American Society for Nutritional Sciences J. Nutr. 133:2635-2638, August 2003


Nutritional Immunology
Research Communication

Iron-Deficient Mice Fail to Develop Autoimmune Encephalomyelitis

Sharon M. Grant, Jason A. Wiesinger, John L. Beard and Margherita T. Cantorna2

Department of Nutrition, The Pennsylvania State University, 126 South Henderson, University Park, PA 16802

2To whom correspondence should be addressed. E-mail: mxc69{at}psu.edu.

Determinations of the effects of iron status on the immune system are complicated by the fact that microorganisms and immune cells both utilize iron. To determine the role of iron in immune function, we utilized a model [experimental autoimmune encephalomyelitis (EAE)] in which a strong antigen-specific CD4+ T-cell response develops in the absence of infection. EAE is an autoimmune disease frequently used as a model for the human disease multiple sclerosis (MS). EAE was induced in B10.PL mice fed low iron (1 mg/kg), normal iron (10 mg/kg) or high iron (160 mg/kg) diets that were replete in all other nutrients. Liver iron measurements verified iron status, i.e., low iron mice had 1.9 µmol/g tissue, normal iron mice, 3.27 µmol/g tissue and high iron mice, 5.35 µmol/g tissue. EAE symptoms were most severe in normal iron mice, and EAE did not develop in low iron mice. The incidence of EAE was 71% in normal iron mice, 62% in iron-overloaded mice and 0% in iron-deficient mice. Two of seven mice in the normal iron group developed severe EAE and were euthanized. None of the iron-overloaded mice developed severe EAE. Other measures of EAE severity were similar in the normal and iron-overloaded mice. The data suggest that iron deficiency provides protection from the development of EAE and that iron excess with its potential contribution to free radical formation was not an important factor. The mechanism of EAE inhibition in iron-deficient mice likely involves the delivery and metabolism of iron for optimal CD4+ T-cell development.


KEY WORDS: • iron • experimental autoimmune encephalomyelitis • multiple sclerosis • mice




This article has been cited by other articles:


Home page
Mult SclerHome page
K.M. Mitchell, A.L. Dotson, K.M. Cool, A. Chakrabarty, S.H. Benedict, and S.M. LeVine
Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis
Multiple Sclerosis, November 1, 2007; 13(9): 1118 - 1126.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
Y. Ge, J.H. Jensen, H. Lu, J.A. Helpern, L. Miles, M. Inglese, J.S. Babb, J. Herbert, and R.I. Grossman
Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging
AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1639 - 1644.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. Ehrenreich, B. Fischer, C. Norra, F. Schellenberger, N. Stender, M. Stiefel, A.-L. Siren, W. Paulus, K.-A. Nave, R. Gold, et al.
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
Brain, October 1, 2007; 130(10): 2577 - 2588.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
P. Zamboni
The Big Idea: Iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis
J R Soc Med, November 1, 2006; 99(11): 589 - 593.
[Full Text] [PDF]


Home page
Mult SclerHome page
C. Sfagos, A. C Makis, A. Chaidos, E. C Hatzimichael, A. Dalamaga, K. Kosma, and K. L. Bourantas
Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients
Multiple Sclerosis, June 1, 2005; 11(3): 272 - 275.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
S. Leung, A. Holbrook, B. King, H.-T. Lu, V. Evans, N. Miyamoto, C. Mallari, S. Harvey, D. Davey, E. Ho, et al.
Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators
J Biomol Screen, March 1, 2005; 10(2): 157 - 167.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]